ACI: Q2 revenue rose 26% as bromine grew; SiCSem construction advanced

What happened

ACI reported Q2FY27 revenue of Rs. 302 crore, up 26% year over year, with growth in bromine and derivatives. Consolidated EBITDA, a measure of operating earnings before interest, taxes, depreciation and amortization, rose 7.9%, while first-half EBITDA and profit after tax declined year over year. SiCSem construction is underway.

Confirmed

Global impact / market context

Higher quarterly revenue alongside lower first-half operating earnings and profit after tax points to uneven performance across the reported periods. If bromine and derivatives growth continues, it could support sales, but the figures do not establish that revenue growth is translating into stronger earnings or cash available.

Analyst inference

The update combines a reported rise in quarterly sales with declines in first-half earnings and profit, while construction at SiCSem continues. Construction can require capital spending before it contributes revenue, so progress may matter to future costs and earnings, but no project spending or expected returns are stated.

Analyst inference

What to watch

1. Watch whether future updates show bromine and derivatives sustaining revenue growth and whether operating earnings begin to grow alongside sales. Analyst inference
2. Look for disclosed progress on SiCSem construction, including any stated timing, capital spending needs, or expected start of operations. Analyst inference
3. Compare later first-half or full-year EBITDA and profit after tax with prior-year figures to see whether the reported declines persist. Analyst inference

Evidence

• Original source link unavailable